• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    $APLS
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate
    Get the next $AEIS alert in real time by email

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600:

    • S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.
    • Dutch Bros Inc. (NYSE:BROS) will replace PotlatchDeltic Corp. (NASD: PCH) in the S&P MidCap 400 effective prior to the opening of trading on Monday, February 2. S&P MidCap 400 constituent Rayonier Inc. (NYSE:RYN) is acquiring PotlatchDeltic in a deal expected to be completed soon, pending final closing conditions. Rayonier will remain in the S&P MidCap 400 post-merger.
    • S&P SmallCap 600 constituent Advanced Energy Industries Inc. (NASD: AEIS) will replace Comerica Inc. (NYSE:CMA) in the S&P MidCap 400, and Apellis Pharmaceuticals Inc. (NASD: APLS) will replace Advanced Energy Industries in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 2. S&P 500 constituent Fifth Third Bancorp (NASD: FITB) is acquiring Comerica in a deal expected to be completed soon, pending final closing conditions.
    • American Healthcare REIT Inc. (NYSE:AHR) will replace Cadence Bank (NYSE:CADE) in the S&P MidCap 400 effective prior to the opening of trading on Monday, February 2. S&P 500 constituent Huntington Bancshares Inc. (NASD: HBAN) is acquiring Cadence Bank in a deal expected to be completed soon, pending final closing conditions.
    • LegalZoom.com Inc. (NASD: LZ) will replace Elme Communities (NYSE:ELME) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 2. Elme Communities has announced ongoing liquidation activities and is no longer appropriate for the S&P SmallCap 600.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    Jan 30, 2026

    S&P MidCap 400

    Addition

    TTM Technologies

    TTMI

    Information Technology

    Jan 30, 2026

    S&P MidCap 400

    Deletion

    Civitas Resources

    CIVI

    Energy

    Jan 30, 2026

    S&P SmallCap 600

    Addition

    Amneal Pharmaceuticals

    AMRX

    Health Care

    Jan 30, 2026

    S&P SmallCap 600

    Deletion

    TTM Technologies

    TTMI

    Information Technology

    Feb 2, 2026

    S&P MidCap 400

    Addition

    Dutch Bros

    BROS

    Consumer Discretionary

    Feb 2, 2026

    S&P MidCap 400

    Addition

    Advanced Energy Industries

    AEIS

    Information Technology

    Feb 2, 2026

    S&P MidCap 400

    Addition

    American Healthcare REIT

    AHR

    Real Estate

    Feb 2, 2026

    S&P MidCap 400

    Deletion

    Comerica

    CMA

    Financials

    Feb 2, 2026

    S&P MidCap 400

    Deletion

    Cadence Bank

    CADE

    Financials

    Feb 2, 2026

    S&P MidCap 400

    Deletion

    PotlatchDeltic

    PCH

    Real Estate

    Feb 2, 2026

    S&P SmallCap 600

    Addition

    Apellis Pharmaceuticals

    APLS

    Health Care

    Feb 2, 2026

    S&P SmallCap 600

    Addition

    LegalZoom.com

    LZ

    Industrials

    Feb 2, 2026

    S&P SmallCap 600

    Deletion

    Advanced Energy Industries

    AEIS

    Information Technology

    Feb 2, 2026

    S&P SmallCap 600

    Deletion

    Elme Communities

    ELME

    Real Estate

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected] 

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/ttm-technologies-dutch-bros-advanced-energy-industries-and-american-healthcare-reit-set-to-join-sp-midcap-400-others-to-join-sp-smallcap-600-302671845.html

    SOURCE S&P Dow Jones Indices

    Get the next $AEIS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEIS
    $AHR
    $AMRX
    $APLS

    CompanyDatePrice TargetRatingAnalyst
    Amneal Pharmaceuticals Inc.
    $AMRX
    4/17/2026$19.00Buy
    UBS
    Dutch Bros Inc.
    $BROS
    4/8/2026$66.00Outperform
    Telsey Advisory Group
    SM Energy Company
    $SM
    4/8/2026$33.00Buy → Neutral
    Roth Capital
    Fifth Third Bancorp
    $FITB
    4/7/2026$55.00Buy
    Goldman
    Dutch Bros Inc.
    $BROS
    3/30/2026$73.00Outperform
    BNP Paribas Exane
    SM Energy Company
    $SM
    3/24/2026$38.00Buy
    Truist
    SM Energy Company
    $SM
    3/20/2026$40.00Neutral → Overweight
    Analyst
    Fifth Third Bancorp
    $FITB
    3/16/2026$50.50Overweight
    Analyst
    More analyst ratings

    $AEIS
    $AHR
    $AMRX
    $APLS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEIS
    $AHR
    $AMRX
    $APLS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CEO & Chairman Steinour Stephen D bought $499,971 worth of shares (32,277 units at $15.49), increasing direct ownership by 2% to 1,442,845 units (SEC Form 4)

    4 - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Issuer)

    3/16/26 6:41:11 PM ET
    $HBAN
    Major Banks
    Finance

    Director Rollins James D Iii bought $1,500 worth of Dep Shares-int in 4.50% Ser H Non-Cum Perp Pref Stk (85 units at $17.65) and bought $28,614 worth of Dep Shares-int in 6.875 % Ser J Non-Cum Perp Pref Stk (1,127 units at $25.39), decreasing direct ownership by 19% to 4,000 units (SEC Form 4)

    4 - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Issuer)

    3/9/26 5:53:38 PM ET
    $HBAN
    Major Banks
    Finance

    Director Rollins James D Iii bought $86,750 worth of Dep Shares-int in 4.50% Ser H Non-Cum Perp Pref Stk (4,915 units at $17.65) (SEC Form 4)

    4 - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Issuer)

    3/4/26 4:57:31 PM ET
    $HBAN
    Major Banks
    Finance

    $AEIS
    $AHR
    $AMRX
    $APLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS initiated coverage on Amneal Pharmaceuticals with a new price target

    UBS initiated coverage of Amneal Pharmaceuticals with a rating of Buy and set a new price target of $19.00

    4/17/26 8:10:24 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Telsey Advisory Group initiated coverage on Dutch Bros with a new price target

    Telsey Advisory Group initiated coverage of Dutch Bros with a rating of Outperform and set a new price target of $66.00

    4/8/26 8:35:55 AM ET
    $BROS
    Restaurants
    Consumer Discretionary

    SM Energy downgraded by Roth Capital with a new price target

    Roth Capital downgraded SM Energy from Buy to Neutral and set a new price target of $33.00

    4/8/26 8:30:25 AM ET
    $SM
    Oil & Gas Production
    Energy

    $AEIS
    $AHR
    $AMRX
    $APLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Lopper Jeffrey A

    4 - FIFTH THIRD BANCORP (0000035527) (Issuer)

    4/21/26 4:49:45 PM ET
    $FITB
    Major Banks
    Finance

    SEC Form 4 filed by Khanna Kevin J

    4 - FIFTH THIRD BANCORP (0000035527) (Issuer)

    4/21/26 4:50:28 PM ET
    $FITB
    Major Banks
    Finance

    SEC Form 4 filed by Wasechek Wayne

    4 - RAYONIER INC (0000052827) (Issuer)

    4/21/26 7:48:35 AM ET
    $RYN
    Real Estate Investment Trusts
    Real Estate

    $AEIS
    $AHR
    $AMRX
    $APLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader

    The proposed combination will create a differentiated global biosimilars platform that leverages Kashiv BioSciences' development and manufacturing capabilities with Amneal Pharmaceuticals' commercial strengths Complementary acquisition will accelerate biosimilar pipeline and strengthen U.S. commercial position for affordable medicines Kashiv BioSciences, LLC ("Kashiv"), today announced that it has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) ("Amneal"). The transaction is subject to approval by Amneal shareholders, receipt of regulatory approvals and satisfaction of customary closing conditions and is expected to close in the second ha

    4/22/26 6:17:00 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

    – Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity – – Transaction Accelerates Growth Profile and Diversification – – Preliminary Q1 Results Reflect Continued Growth and Raising 2026 Full Year Guidance – – Company to Host Investor Conference Call Today at 8:30 a.m. EST – BRIDGEWATER, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) ("Amneal" or the "Company"), a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines, today announced that it has entered into a definitive agreement to acquire 100% of Kashiv BioSciences, LLC ("Kashiv") in a transaction w

    4/22/26 6:00:00 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Huntington Bank Expands Commercial Banking into Austin

    Middle-Market, Corporate Banking Expansion Follows Bank's Significant Growth in Texas COLUMBUS, Ohio, April 21, 2026 /PRNewswire/ -- Huntington National Bank continues to expand its commercial banking segment, known as Huntington Commercial Bank, across the U.S. by bringing its middle-market and corporate banking capabilities to Austin and central Texas. The commercial expansion follows Huntington's significant growth in Texas, including the recent acquisitions of Houston-based Cadence Bank and Dallas-based Veritex Bank. With Cadence and Veritex, Huntington is now the eighth lar

    4/21/26 4:30:00 PM ET
    $HBAN
    Major Banks
    Finance

    $AEIS
    $AHR
    $AMRX
    $APLS
    SEC Filings

    View All

    SEC Form DEFA14A filed by Amneal Pharmaceuticals Inc.

    DEFA14A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer)

    4/22/26 6:24:08 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amneal Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Entry into a Material Definitive Agreement, Regulation FD Disclosure

    8-K - Amneal Pharmaceuticals, Inc. (0001723128) (Filer)

    4/22/26 6:22:26 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Rayonier Inc. REIT

    144 - RAYONIER INC (0000052827) (Subject)

    4/21/26 3:17:18 PM ET
    $RYN
    Real Estate Investment Trusts
    Real Estate

    $AEIS
    $AHR
    $AMRX
    $APLS
    Leadership Updates

    Live Leadership Updates

    View All

    Fifth Third Bancorp Announces Preliminary Results of Annual Shareholders Meeting

    Fifth Third Bancorp (NASDAQ:FITB) has announced that preliminary results from the Annual Shareholders Meeting held earlier today have indicated the following directors were re-elected: Timothy N. Spence, chairman, CEO and president, Fifth Third Bancorp. Nicholas K. Akins, retired chairman, president and CEO, American Electric Power. Priscilla Almodovar, former president and CEO, Federal National Mortgage Association (Fannie Mae). Evan Bayh III, senior advisor, Apollo Global Management. Jorge L. Benitez, retired CEO of North America, Accenture. Katherine B. Blackburn, executive vice president, Cincinnati Bengals, Inc. Linda W. Clement-Holmes, retired chief information of

    4/21/26 4:15:00 PM ET
    $FITB
    Major Banks
    Finance

    Diebold Nixdorf Set to Join S&P SmallCap 600

    NEW YORK, April 7, 2026 /PRNewswire/ -- Diebold Nixdorf Inc. (NYSE:DBD) will replace Sealed Air Corp. (NYSE:SEE) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, April 10. Clayton, Dubilier & Rice LLC is acquiring Sealed Air in a deal expected to be completed April 9. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorApril 10, 2026S&P SmallCap 600AdditionDiebold NixdorfDBDInformation TechnologyApril 10, 2026S&P SmallCap 600DeletionSealed AirSEEMaterialsABOUT S&P DOW JONES INDICESS&P Dow Jones Indices is the largest global resource for essen

    4/7/26 5:47:00 PM ET
    $DBD
    $SEE
    $SPGI
    Office Equipment/Supplies/Services
    Miscellaneous
    Major Chemicals
    Industrials

    Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson's Awareness Month

    BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ:AMRX) today announced donations totaling $2 million to multiple patient assistance foundations supporting individuals living with Parkinson's disease (PD) in recognition of Parkinson's Awareness Month. These contributions reflect Amneal's ongoing commitment to expanding access to essential medicines and supporting patient care, education, and advocacy for the Parkinson's community. Every six minutes, someone in the United States is diagnosed with Parkinson's disease, underscoring the growing impact of a condition that affects more than 10 million people worldwide. As the

    4/7/26 8:00:00 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEIS
    $AHR
    $AMRX
    $APLS
    Financials

    Live finance-specific insights

    View All

    Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

    – Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity – – Transaction Accelerates Growth Profile and Diversification – – Preliminary Q1 Results Reflect Continued Growth and Raising 2026 Full Year Guidance – – Company to Host Investor Conference Call Today at 8:30 a.m. EST – BRIDGEWATER, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) ("Amneal" or the "Company"), a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines, today announced that it has entered into a definitive agreement to acquire 100% of Kashiv BioSciences, LLC ("Kashiv") in a transaction w

    4/22/26 6:00:00 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Land & Buildings Announces Investment Opinion: Issues White Paper Detailing Why It Believes Welltower's Compensation Program Is Likely to Lead to Inferior Shareholder Returns

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Land & Buildings Investment Management, LLC Welltower Shares Trade at 144% Premium to NAV and 33x FFO: Investors Switching to Ventas or American Healthcare REIT Receive 50% More Asset Value Per Dollar Estimates Shares Could See ~35%-60% Downside From Current Levels to Match Peer Valuations – Discloses Short Position in Welltower Today, Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings," "L&B," "us" or "we"), issued a white paper on Welltower, Inc. (NYSE:WELL) ("Welltower" or the "Company"), titled Compensation Plan Hubris: Why Welltower's Ten-Year Executive Program Is Likely to

    4/21/26 9:05:00 AM ET
    $AHR
    $ARE
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Advanced Energy Announces First Quarter 2026 Earnings Date on May 4

    Advanced Energy (NASDAQ:AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, will report its first quarter 2026 financial results after the market closes on Monday, May 4, 2026. Management's quarterly conference call will be held the same day beginning at 4:30 p.m. Eastern Time. To participate in the live earnings conference call, please dial 877-407-0890 approximately ten minutes prior to the start of the meeting and an operator will connect you. International participants can dial +1-201-389-0918. A live webcast of the call will be available on the Investors page of the company's website at ir.advancedenergy.com in the Events & P

    4/21/26 6:00:00 AM ET
    $AEIS
    Industrial Machinery/Components
    Technology

    $AEIS
    $AHR
    $AMRX
    $APLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Apellis Pharmaceuticals Inc.

    SC 13G - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 8:47:59 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dutch Bros Inc.

    SC 13G/A - Dutch Bros Inc. (0001866581) (Subject)

    11/14/24 4:21:31 PM ET
    $BROS
    Restaurants
    Consumer Discretionary